Worldwide Single Use Bioreactors Industry to 2025 - Featuring Merck Millipore, Getinge & Eppendorf Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Single Use Bioreactors Market by Product (System, Media Bag, Filtration Assemblies), Type (Stirred Tank, Bubble Column), Type of Molecule (MAbs, Vaccine), Cell Type (Mammalian, Bacteria), Application (R&D), End User (CROs & CMOs) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global single-use bioreactors (SUBs) market is projected to reach USD 3.90 billion by 2025 from USD 1.71 billion in 2020, at a CAGR of 18.0% during the forecast period.

Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption, the growing biologics market, technological advancements in SUBs, and increasing Biopharmaceutical R&D are factors driving the growth of this market.

By type, the stirred-tank SUBs segment accounted for the largest share of the single-use bioreactors market

The single-use bioreactors market is categorized into major four types, wave-induced SUBs, stirred-tank SUBs, bubble-column SUBs, and other bioreactors. The stirred-tank SUBs segment dominated the single-use bioreactors market in 2019. The large share of this segment can be attributed to factors such as the high preference for stirred-tank SUBs in the cultivation of aerobic microbial cultures due to its ability to provide greater oxygen transfer and reduced engineering challenges such as heat removal, mass transfer, and higher agitation rates.

Asia Pacific: The fastest-growing region in the single-use bioreactors market.

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the growing biopharmaceutical industry, increasing life science research, rising investments by pharmaceutical and biotechnology companies, and the growing number of CROs and CMOs in several APAC countries contribute to its growth.

North America: the largest share of the single-use bioreactors market

North America accounted for the largest share of the single-use bioreactors market. Factors such as the presence of established biopharmaceutical industry and the presence of major players operating in the single-use bioreactors market in the region are the major factors driving the market growth.

Market Dynamics

Drivers

• Increasing Adoption of Subs Among Small Companies and Startups
• Reduced Automation Complexity
• Ease in the Cultivation of Marine Organisms
• Reduced Energy and Water Consumption
• Growing Biologics Market
• Technological Advancements in Subs
• Increasing Biopharmaceutical R&D

Restraints

• Regulatory Concerns Related to Subs
• Issues Related to Leachables and Extractables

Opportunities

• Patent Expiry
• Emerging Markets

Challenges

• Need for Improved Single-Use Sensors
• Standardization of Single-Use Designs

Companies Profiled

• Sartorius Stedim Biotech
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Merck Millipore
• Getinge Ab
• Eppendorf Ag
• Cesco Bioengineering Co., Ltd.
• Cellexus
• PBS Biotech, Inc.
• Distek, Inc.
• ABEC, Inc.
• Able Corporation & Biott Corporation
• G&G Technologies, Inc.
• Solida Biotech GmbH
• Satake Chemical Equipment Mfg., Ltd.
• Stobbe Pharma GmbH
• Celltainer Biotech Bv
• Meissner Filtration Products, Inc.
• Bbi-Biotech GmbH
• Pierre Gurin

For more information about this report visit https://www.researchandmarkets.com/r/utnjab